| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11136-004-3928-3 |
| P698 | PubMed publication ID | 15789955 |
| P50 | author | Jeffrey A Johnson | Q38802305 |
| P2093 | author name string | A Simon Pickard | |
| David H Feeny | |||
| P2860 | cites work | What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D | Q24796975 |
| The MOS 36-ltem Short-Form Health Survey (SF-36) | Q26778425 | ||
| Classification and natural history of clinically identifiable subtypes of cerebral infarction | Q28244314 | ||
| EuroQol: the current state of play | Q33571065 | ||
| Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. | Q33648354 | ||
| Use of the Barthel index and modified Rankin scale in acute stroke trials. | Q33870093 | ||
| A comparative review of generic quality-of-life instruments | Q33881659 | ||
| Identifying meaningful intra-individual change standards for health-related quality of life measures | Q33916167 | ||
| Methods for assessing responsiveness: a critical review and recommendations | Q33919427 | ||
| Longitudinal construct validity: establishment of clinical meaning in patient evaluative instruments | Q34029355 | ||
| Interobserver agreement for the assessment of handicap in stroke patients. | Q34176187 | ||
| Introducing economic and quality of life measurements into clinical studies | Q34329579 | ||
| A meta-analysis of quality-of-life estimates for stroke | Q35056737 | ||
| Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting | Q35563171 | ||
| Modeling valuations for EuroQol health states | Q39513119 | ||
| Quality of life measurement after stroke: uses and abuses of the SF-36. | Q39601184 | ||
| The estimation of a preference-based measure of health from the SF-36. | Q40647897 | ||
| Integrating response shift into health-related quality of life research: a theoretical model | Q40806505 | ||
| Measuring health-related quality of life | Q40885951 | ||
| A randomised comparison of the EuroQol and Short Form-36 after stroke. United Kingdom collaborators in the International Stroke Trial | Q41813577 | ||
| Relation of distribution- and anchor-based approaches in interpretation of changes in health-related quality of life | Q43789921 | ||
| Effect sizes for interpreting changes in health status. | Q43872888 | ||
| A critical look at transition ratings | Q44051595 | ||
| Comparison of the standard gamble, rating scale, AQLQ and SF-36 for measuring quality of life in asthma | Q45221246 | ||
| A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments | Q47618006 | ||
| Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. | Q50489081 | ||
| Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey. | Q50497335 | ||
| Quality of life in epilepsy: comparison of four preference measures. | Q50894997 | ||
| Qualitative comparison of the reliability of health status assessments with the EuroQol and SF-36 questionnaires after stroke. United Kingdom Collaborators in the International Stroke Trial. | Q51099721 | ||
| Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. | Q51648082 | ||
| Comparing the sensitivity of generic effectiveness measures with symptom improvement in persons with schizophrenia. | Q51950878 | ||
| Comparison of three measures of quality of life outcome in the evaluation of continuous positive airways pressure therapy for sleep apnoea. | Q51998227 | ||
| Validation of the Short Form 36 (SF-36) health survey questionnaire among stroke patients. | Q52007374 | ||
| Measuring changes in quality of life following magnetic resonance imaging of the knee: SF-36, EuroQol or Rosser index? | Q53387777 | ||
| Comparison of the Health Utilities Index Mark 3 (HUI3) and the EuroQol EQ-5D in patients treated for intermittent claudication. | Q53494633 | ||
| Measurement of health outcomes in treatment effectiveness evaluations: conceptual and methodological challenges. | Q53513123 | ||
| Generic and condition-specific outcome measures for people with osteoarthritis of the knee. | Q53540254 | ||
| Intermittent claudication: symptom severity versus health values. | Q53580284 | ||
| Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. | Q54245872 | ||
| Comparison of the responsiveness of the Barthel Index and the Motor Component of the Functional Independence Measure in stroke | Q59603658 | ||
| Stroke Recovery Profile and the Modified Rankin Assessment | Q59603727 | ||
| Health Status of Individuals With Mild Stroke | Q59603848 | ||
| The sensitivity and specificity of the Center for Epidemiologic Studies Depression Scale in screening for post-stroke depression | Q67930594 | ||
| Measurements of acute cerebral infarction: a clinical examination scale | Q69660651 | ||
| Screening for depression in stroke patients: the reliability and validity of the Center for Epidemiologic Studies Depression Scale | Q70038167 | ||
| Use of the Health Utilities Index with stroke patients and their caregivers | Q73814707 | ||
| Methodological inquiries in health status assessment | Q74449181 | ||
| Comparative responsiveness of generic versus disease-specific and weighted versus unweighted health status measures in carpal tunnel syndrome | Q74449189 | ||
| Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease | Q78159339 | ||
| P433 | issue | 1 | |
| P921 | main subject | quality of life | Q13100823 |
| P304 | page(s) | 207-219 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | Quality of Life Research | Q15749950 |
| P1476 | title | Responsiveness of generic health-related quality of life measures in stroke | |
| P478 | volume | 14 |
| Q57814958 | A Patient-Centered Utility Index for Non-Small Cell Lung Cancer in the United States |
| Q51735862 | A comparison of the performance of the EQ-5D and SF-6D for individuals aged >or= 45 years. |
| Q36503744 | A longitudinal comparison of 5 preference-weighted health state classification systems in persons with intervertebral disk herniation |
| Q33669647 | A review of health utilities using the EQ-5D in studies of cardiovascular disease |
| Q38157041 | A systematic literature review of cardiovascular event utilities |
| Q28194211 | An Introduction to Economic Evaluation in Occupational Therapy: Cost-Effectiveness of Pre-Discharge Home Visits after Stroke (HOVIS) |
| Q24805172 | Are decisions using cost-utility analyses robust to choice of SF-36/SF-12 preference-based algorithm? |
| Q53130831 | Assessment of a patient with stroke neurological examination and clinical rating scales. |
| Q36172364 | Can The EQ-5D Detect Meaningful Change? A Systematic Review. |
| Q36087642 | Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints. |
| Q35030613 | Clinical efficacy and cost-effectiveness of lanthanum carbonate as second-line therapy in hemodialysis patients in Japan. |
| Q91805091 | Commentary. In Praise of Studies That Use More Than One Generic Preference-Based Measure |
| Q38863771 | Comparative performance of the EQ-5D-5L and SF-6D index scores in adults with type 2 diabetes |
| Q53157395 | Comparing preference-based quality-of-life measures: results from rehabilitation patients with musculoskeletal, cardiovascular, or psychosomatic disorders. |
| Q35687316 | Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients. |
| Q37289472 | Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain |
| Q33615866 | Comparison of 5 health-related quality-of-life indexes using item response theory analysis |
| Q51918860 | Comparison of EQ-5D and SF-6D utilities in mental health patients. |
| Q46367218 | Comparison of health-related quality of life measures for chronic renal failure: quality of well-being scale, short-form-6D, and the kidney disease quality of life instrument |
| Q38647577 | Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease. |
| Q34667255 | Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease |
| Q36415874 | Complications among colorectal cancer survivors: SF-6D preference-weighted quality of life scores |
| Q37272199 | Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis |
| Q44601016 | Cost-effectiveness of oral appliances in the treatment of obstructive sleep apnoea-hypopnoea |
| Q51896935 | Determinants of change in quality of life from 1 to 6 months following acute stroke. |
| Q48461438 | Determining quality of life in stroke survivors |
| Q50129904 | Differences in utility elicitation methods in cardiovascular disease: a systematic review |
| Q36494300 | EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). |
| Q37372473 | Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial |
| Q35177004 | Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke |
| Q48020621 | Exploring the Potential Cost-Effectiveness of Patient Decision Aids for Use in Adults with Obstructive Sleep Apnea: A Case Study. |
| Q36092269 | Health utility after emergency medical admission: a cross-sectional survey |
| Q36205962 | Health-related quality of life in stroke patients questionnaire, short version (HRQOLISP-40): validation for its use in Colombia |
| Q51871557 | How consistent are health utility values? |
| Q51910391 | Impact of recombinant activated factor VII on health-related quality of life after intracerebral hemorrhage. |
| Q40103881 | Impact of the recall period on measuring health utilities for acute events |
| Q37314524 | Importance of sociodemographic and morbidity aspects in measuring health-related quality of life: performances of three tools: comparison of three questionnaire scores |
| Q36689858 | Mapping health outcome measures from a stroke registry to EQ-5D weights. |
| Q43937776 | Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome |
| Q38797496 | Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid Carcinoma |
| Q53239300 | Measuring health status and decline in at-risk seniors residing in the community using the Health Utilities Index Mark 2. |
| Q34614168 | Measuring preferences for cost-utility analysis: how choice of method may influence decision-making |
| Q90113070 | Optimizing functional outcome endpoints for stroke recovery studies |
| Q36391919 | Patients undergoing subacute rehabilitation have accurate expectations of their health-related quality of life at discharge |
| Q35865573 | Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments |
| Q33950572 | Personality and EQ-5D scores among individuals with chronic conditions |
| Q45743440 | Post-stroke depression and functional independence: a conundrum |
| Q45324181 | Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy? |
| Q48692443 | Psychometric properties of a revised version of the Visual Analog Mood Scales |
| Q34461509 | Reference bias: presentation of extreme health states prior to EQ-VAS improves health-related quality of life scores. a randomised cross-over trial |
| Q38185481 | Responsiveness of the EQ-5D to clinical change: is the patient experience adequately represented? |
| Q35867796 | SF-6D and EQ-5D result in widely divergent incremental cost-effectiveness ratios in a clinical trial of older women: implications for health policy decisions |
| Q38933177 | Self management programmes for quality of life in people with stroke |
| Q37351940 | Sex differences in the relative contribution of social and clinical factors to the Health Utilities Index Mark 2 measure of health-related quality of life in older home care clients |
| Q62384037 | Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses |
| Q34413033 | Social and economic costs and health-related quality of life in stroke survivors in the Canary Islands, Spain |
| Q35981851 | Socio-economic differences in the health-related quality of life impact of cardiovascular conditions. |
| Q57821226 | Socioeconomic Inequalities in Health-Related Quality of Life among Patients with Cardiovascular Diseases in Vietnam |
| Q44255382 | Statistical implications of utility weighted and equally weighted HRQL measures: an empirical study |
| Q37945042 | Systematic review and empirical comparison of contemporaneous EQ-5D and SF-6D group mean scores |
| Q48572096 | Testing for differential item functioning within the EQ-5D. |
| Q43723190 | The association of survey language (Spanish vs. English) with Health Utilities Index and EQ-5D index scores in a United States population sample |
| Q49048441 | The classification systems of the EQ-5D, the HUI II and the SF-6D: what do they have in common? |
| Q51910331 | The impact of literacy on health-related quality of life measurement and outcomes in cancer outpatients. |
| Q40235063 | The mathematical relationship among different forms of responsiveness coefficients |
| Q45254387 | The relationship between body mass index and health-related quality of life: comparing the EQ-5D, EuroQol VAS and SF-6D. |
| Q39122326 | Validation of the EQ-5D in Patients with Traumatic Limb Injury. |
| Q48660503 | Validation of the EuroQol quality of life questionnaire on stroke victims |
| Q35197189 | Validity of EQ-5D-5L in stroke |
| Q48577065 | Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation |
| Q38926921 | Validity, responsiveness, and minimal clinically important difference of EQ-5D-5L in stroke patients undergoing rehabilitation. |
| Q37808208 | Value of information in the osteoarthritis setting: cost effectiveness of COX-2 selective inhibitors, traditional NSAIDs and proton pump inhibitors |
| Q48315614 | Valuing benefits to inform a clinical trial in pharmacy : do differences in utility measures at baseline affect the effectiveness of the intervention? |
| Q42962147 | Visual analogue scales in stroke: what can they tell us about health-related quality of life? |
Search more.